No profile data available.
Ionis Pharmaceuticals, Inc. (IONS) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Carlsbad, United States, with about 1,480 full-time employees.
It reported revenue of $943.71 million for fiscal year 2025, up 33.8% from fiscal year 2024, and net income of -$381.39 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $267.95 million, down 40.7% from a year before. Its market capitalization was $7.52 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
Ionis Pharmaceuticals reported $943.71 million in revenue for fiscal year 2025, up 33.8% from $705.14 million in fiscal year 2024. In Q2 2026 revenue was $267.95 million.
$7.52 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Royalty Pharma plc (RPRX), Viatris Inc. (VTRS), Dr. Reddy's Laboratories Limited (RDY), Amneal Pharmaceuticals, Inc. (AMRX).